Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TXG

10x Genomics Inc

Sep 15 • 04:00PM ET

13.35

+0.71 5.62 %

Healthcare • Health Information Services • USA • NASD

Peers: ILMN NTRA PACB FLGT CDNA MYGN GH EXAS QDEL TWST

| Held by: ARKK VTI ARKG VB IWM VBK VXF IWN IBB JSMD

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.70	Insider Own	11.30%	Shs Outstand	114.36M	Perf Week	-4.16%
Market Cap	1.66B	Forward P/E	-	EPS next Y	-0.96	Insider Trans	-0.42%	Shs Float	110.42M	Perf Month	0.83%
Enterprise Value	1.30B	PEG	-	EPS next Q	-0.29	Inst Own	98.51%	Short Float	12.44%	Perf Quarter	28.18%
Income	-84.60M	P/S	2.58	EPS this Y	59.48%	Inst Trans	6.17%	Short Ratio	4.16	Perf Half Y	29.11%
Sales	644.47M	P/B	2.15	EPS next Y	-56.15%	ROA	-8.86%	Short Interest	13.74M	Perf YTD	-7.03%
Book/sh	6.21	P/C	3.72	EPS next 5Y	24.14%	ROE	-11.30%	52W High	24.38 -45.24%	Perf Year	-39.59%
Cash/sh	3.59	P/FCF	29.22	EPS past 3/5Y	-42.17% -36.10%	ROIC	-9.95%	52W Low	6.78 96.90%	Perf 3Y	-60.74%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	7.59% 19.96%	Gross Margin	71.72%	Volatility	5.53% 4.46%	Perf 5Y	-87.67%
Dividend TTM	-	EV/Sales	2.02	EPS Y/Y TTM	65.33%	Oper. Margin	-23.29%	ATR (14)	0.69	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.23	Sales Y/Y TTM	2.02%	Profit Margin	-13.13%	RSI (14)	50.22	Recom	2.25
Dividend Gr. 3/5Y	- -	Current Ratio	5.84	EPS Q/Q	187.90%	SMA20	-1.60%	Beta	2.08	Target Price	14.87
Payout	-	Debt/Eq	0.11	Sales Q/Q	12.93%	SMA50	1.17%	Rel Volume	0.80	Prev Close	12.64
Employees	1306	LT Debt/Eq	0.10	Earnings	Aug 07 AMC	SMA200	11.43%	Avg Volume	3.30M	Price	13.35
IPO	Sep 12, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	175.72% 24.00%	Trades		Volume	2,629,337	Change	5.62%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-11-25	Initiated	Piper Sandler	Neutral	$15
Feb-13-25	Downgrade	Leerink Partners	Outperform → Market Perform	$25 → $12
Sep-03-24	Initiated	Leerink Partners	Outperform	$35
Jul-22-24	Upgrade	Jefferies	Hold → Buy	$24
Jul-18-24	Downgrade	JP Morgan	Overweight → Neutral	$40 → $20
Jul-10-24	Downgrade	Deutsche Bank	Buy → Hold	$55 → $25
Jun-27-24	Downgrade	Wolfe Research	Outperform → Peer Perform
Jun-25-24	Downgrade	Guggenheim	Buy → Neutral
Jun-03-24	Resumed	Jefferies	Hold	$24
May-01-24	Downgrade	TD Cowen	Buy → Hold	$57 → $32
Dec-14-23	Initiated	Guggenheim	Buy	$60
Dec-13-23	Initiated	Wolfe Research	Outperform	$55
Dec-12-23	Upgrade	BofA Securities	Underperform → Neutral	$36 → $54
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-10-23	Initiated	Barclays	Overweight	$65
Mar-31-23	Initiated	Stephens	Overweight	$65
Feb-02-23	Initiated	UBS	Neutral	$50
Dec-14-22	Initiated	Deutsche Bank	Buy	$50
Aug-18-22	Downgrade	Goldman	Neutral → Sell	$55 → $35
Jul-25-22	Initiated	Canaccord Genuity	Buy	$55

Show Previous Ratings

Sep-12-25 02:25PM	10x Genomics (TXG) Stock Trades Down, Here Is Why (StockStory)
Sep-11-25 11:56AM	10x Genomics (TXG) Stock Is Up, What You Need To Know (StockStory)
Sep-09-25 08:44AM	TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell? (Zacks)
Aug-27-25 04:05PM	10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference (PR Newswire)
Aug-24-25 11:34PM	Q2 Earnings Highs And Lows: 10x Genomics (NASDAQ:TXG) Vs The Rest Of The Life Sciences Tools & Services Stocks (StockStory)
12:04AM	Loading…
Aug-22-25 12:04AM	3 Reasons TXG is Risky and 1 Stock to Buy Instead (StockStory) +9.16%
Aug-20-25 12:37AM	1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down (StockStory)
Aug-19-25 09:00AM	10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis (PR Newswire)
Aug-14-25 01:35AM	10x Genomics's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
12:45AM	1 Volatile Stock to Own for Decades and 2 That Underwhelm (StockStory)
Aug-12-25 10:03AM	Zacks.com featured highlights include Tsakos Energy Navigation Limited, 10x Genomics, Pan American Silver, Wolverine World Wide and Interface (Zacks)
Aug-11-25 09:37AM	TXG Q2 Deep Dive: Robust Product Demand and Cautious Outlook Amid Funding Uncertainty (StockStory)
07:41AM	5 Must-Buy Efficient Stocks to Buy Amid Volatile Market Conditions (Zacks)
Aug-08-25 12:21PM	Why 10x Genomics (TXG) Stock Is Falling Today (StockStory)
04:45AM	10x Genomics (NASDAQ:TXG) Reports Upbeat Q2, Stock Soars (StockStory)
06:30PM	Loading…
Aug-07-25 06:30PM	10x Genomics (TXG) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:35PM	10x Genomics (TXG) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
04:33PM	10x Genomics: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports Second Quarter 2025 Financial Results (PR Newswire)
04:04PM	10x Genomics to Acquire Scale Biosciences (PR Newswire)
Aug-06-25 12:00PM	10x Genomics (TXG) Upgraded to Buy: Here's Why (Zacks)
Aug-05-25 11:09PM	Earnings To Watch: 10x Genomics (TXG) Reports Q2 Results Tomorrow (StockStory)
Aug-01-25 03:00PM	Tempus AI Stock Before Q2 Earnings Release: To Buy or Not to Buy? (Zacks)
Jul-29-25 12:02AM	10x Genomics (TXG): Buy, Sell, or Hold Post Q1 Earnings? (StockStory)
Jul-24-25 12:52PM	10x Genomics Stock Earns RS Rating Upgrade (Investor's Business Daily)
Jul-17-25 09:00AM	10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery (PR Newswire)
Jul-15-25 09:20AM	3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk (Zacks)
Jul-10-25 04:05PM	10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025 (PR Newswire)
Jun-23-25 11:34PM	Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG) (StockStory)
01:39AM	10x Genomics Settles Patent Dispute With Bruker (Insider Monkey)
06:23AM	Loading…
Jun-10-25 06:23AM	TXG Q1 Earnings Call: Academic Funding Uncertainty Drives Guidance Withdrawal and Cost Reductions (StockStory) +5.55%
May-29-25 09:55AM	Wall Street Analysts Think 10x Genomics (TXG) Could Surge 43.12%: Read This Before Placing a Bet (Zacks) +5.36%
May-23-25 07:41AM	Why 10x Genomics Stock Was Sliding This Week (Motley Fool)
May-22-25 02:00AM	Trump Funding Cuts Are Roiling Science. These Stocks May Be Hardest Hit. (Barrons.com)
May-21-25 12:00PM	10x Genomics (TXG) Upgraded to Buy: Here's What You Should Know (Zacks) -8.37%
May-14-25 04:05PM	10x Genomics Announces Patent Litigation Settlement Agreement with Bruker (PR Newswire) -5.49%
01:32PM	Bruker and 10x Genomics settle patent dispute (Medical Device Network)
May-13-25 09:55AM	Wall Street Analysts Believe 10x Genomics (TXG) Could Rally 55.85%: Here's is How to Trade (Zacks)
May-09-25 03:42AM	10x Genomics Inc (TXG) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
May-08-25 07:00PM	Compared to Estimates, 10x Genomics (TXG) Q1 Earnings: A Look at Key Metrics (Zacks)
05:50PM	10x Genomics (TXG) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:53PM	10x Genomics: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports First Quarter 2025 Financial Results (PR Newswire)
May-07-25 05:20PM	10x Genomics Q1 2025 Earnings Preview (Seeking Alpha)
May-01-25 10:01AM	10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-30-25 04:05PM	10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference (PR Newswire)
Apr-28-25 03:00PM	Tempus AI Stock Surges 43% in Q1: Buy Now or Wait for Earnings? (Zacks)
09:09AM	3 Cash-Heavy Stocks in the Doghouse (StockStory)
Apr-14-25 04:05PM	10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025 (PR Newswire)
Apr-09-25 05:04AM	Q4 Earnings Outperformers: 10x Genomics (NASDAQ:TXG) And The Rest Of The Life Sciences Tools & Services Stocks (StockStory) +21.43%
Mar-20-25 03:12AM	10x Genomics: Lower Cost Innovation May Drive A Rebound (SeekingAlpha)
Mar-18-25 07:00AM	These 10 biotech companies are changing how we discover new drugs and treat complex diseases (FastCompany)
Mar-11-25 05:03AM	2 Reasons to Sell TXG and 1 Stock to Buy Instead (StockStory)
Mar-03-25 04:05PM	10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products (PR Newswire) -7.86% +6.80%
08:03AM	1 Stock Under $50 on Our Watchlist and 2 to Ignore (StockStory)
Feb-23-25 11:30AM	10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis (PR Newswire)
Feb-18-25 04:05PM	10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference (PR Newswire)
Feb-13-25 03:10PM	Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties (Benzinga)
01:57PM	Trumps Cuts to Medical Research Are Hurting These Stocks (Barrons.com)
01:53PM	Why 10x Genomics (TXG) Shares Are Falling Today (StockStory)
09:42AM	10x Genomics Shares Tumble on Fear Over Cuts to NIH (Barrons.com)
07:36AM	Q4 2024 10X Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
02:16AM	10x Genomics Inc (TXG) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Feb-12-25 06:30PM	Here's What Key Metrics Tell Us About 10x Genomics (TXG) Q4 Earnings (Zacks)
05:45PM	10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:41PM	10x Genomics: Q4 Earnings Snapshot (Associated Press Finance)
04:39PM	10x Genomics (NASDAQ:TXG) Exceeds Q4 Expectations But Full-Year Sales Guidance Misses Expectations (StockStory)
04:05PM	10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025 (PR Newswire)
Feb-11-25 09:15AM	Seeking Clues to 10x Genomics (TXG) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
08:06AM	10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect (StockStory)
Feb-06-25 08:08PM	10x Genomics, Inc. (TXG): Among Cathie Woods Top Stock Picks for 2025 (Insider Monkey)
08:30AM	Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology (PR Newswire)
Feb-05-25 10:00AM	10x Genomics (TXG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jan-28-25 04:05PM	10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025 (PR Newswire)
Jan-12-25 12:00PM	10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2024 Results (PR Newswire)
Jan-08-25 07:30PM	Colorados Most Expensive Home for Sale Is Listing for $78 Million (The Wall Street Journal)
Jan-02-25 04:05PM	10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire) +9.94%
Dec-30-24 09:28AM	Bruker seeks to pause injunction of GeoMx in the US after court ruling (Medical Device Network)
Dec-24-24 07:30AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Dec-23-24 04:05PM	U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products (PR Newswire)
Nov-20-24 03:29PM	If RFK Jr. Cuts Science Funding, These Instrument Makers May Suffer (Barrons.com)
Nov-19-24 07:11PM	10x Genomics, Inc. (TXG): Among the Best Genomics Stocks to Buy Right Now (Insider Monkey)
Nov-07-24 04:05PM	10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference (PR Newswire)
Oct-31-24 08:00AM	TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery Initiative (PR Newswire)
Oct-30-24 07:36AM	Q3 2024 10X Genomics Inc Earnings Call (Thomson Reuters StreetEvents)
03:14AM	10x Genomics Inc (TXG) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Oct-29-24 07:00PM	10x Genomics (TXG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:20PM	10x Genomics (TXG) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:15PM	10x Genomics: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	10x Genomics Reports Third Quarter 2024 Financial Results (PR Newswire)
Oct-23-24 12:00PM	10x Genomics (TXG) Upgraded to Strong Buy: Here's Why (Zacks)
Oct-22-24 10:01AM	10x Genomics (TXG) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-15-24 04:05PM	10x Genomics Delivers 'Single Cell for a Single Cent' with New Chromium Launches (PR Newswire)
Oct-10-24 04:14PM	These Stocks Moved the Most Today: Tesla, Super Micro, AMD, and More (Barrons.com) -24.70%
01:26PM	These Stocks Are Moving the Most Today: Tesla, Delta, Super Micro, First Solar, AMD, 10x Genomics, PayPal, and More (Barrons.com)
07:36AM	Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead (Benzinga)
Oct-09-24 05:57PM	10x Genomics Inc (TXG) Q2 2024 Earnings Call Highlights: Navigating Growth Amidst Macroeconomic ... (GuruFocus.com)
04:05PM	10x Genomics Announces Preliminary Select Third Quarter 2024 Results (PR Newswire)
Oct-04-24 05:05PM	Vanguard Group's Strategic Acquisition in 10x Genomics Inc (GuruFocus.com)
Oct-01-24 04:05PM	10x Genomics Announces Mega-Scale Single Cell Analysis for One Cent Per Cell at Human Cell Atlas General Meeting (PR Newswire) -5.62% -5.54%

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Saxonov Serge	Chief Executive Officer	Aug 22 '25	Sale	13.79	9,348	128,881	945,892	Aug 26 04:15 PM
Taich Adam	Chief Financial Officer	Aug 22 '25	Sale	13.79	22,315	307,657	309,273	Aug 26 04:14 PM
Hindson Benjamin J.	See Remarks	Aug 22 '25	Sale	13.79	7,486	103,209	440,888	Aug 26 04:12 PM
Saxonov Serge	Officer	Aug 22 '25	Proposed Sale	13.41	9,228	123,747		Aug 22 04:26 PM
Hindson Benjamin J.	Officer	Aug 22 '25	Proposed Sale	13.41	7,393	99,140		Aug 22 04:21 PM
Taich Adam	Officer	Aug 22 '25	Proposed Sale	13.41	22,037	295,516		Aug 22 04:17 PM
Saxonov Serge	Chief Executive Officer	May 22 '25	Sale	8.30	9,343	77,540	1,083,625	May 27 05:08 PM
Hindson Benjamin J.	See Remarks	May 22 '25	Sale	8.30	7,485	62,120	448,374	May 27 05:07 PM
Taich Adam	Chief Financial Officer	May 22 '25	Sale	8.30	4,044	33,562	331,588	May 27 05:06 PM
Hindson Benjamin J.	Officer	May 22 '25	Proposed Sale	9.08	7,392	67,119		May 22 04:44 PM
Taich Adam	Officer	May 22 '25	Proposed Sale	9.08	3,994	36,266		May 22 04:36 PM
Saxonov Serge	Officer	May 22 '25	Proposed Sale	9.08	9,227	83,781		May 22 04:24 PM
Saxonov Serge	Chief Executive Officer	Mar 04 '25	Option Exercise	1.20	50,000	60,000	921,540	Mar 04 06:50 PM
Saxonov Serge	Chief Executive Officer	Feb 28 '25	Sale	10.63	7,942	84,393	871,540	Mar 04 06:50 PM
Serge Saxonov	Director, CEO	Feb 28 '25	Proposed Sale	10.57	7,942	83,947		Feb 28 05:03 PM
Hindson Benjamin J.	See Remarks	Feb 24 '25	Sale	11.07	4,573	50,603	335,324	Feb 26 05:43 PM
Saxonov Serge	Chief Executive Officer	Feb 24 '25	Sale	11.07	5,092	56,346	879,482	Feb 26 05:42 PM
MATEO ALAN	Director	Feb 21 '25	Buy	11.14	40,000	445,572	61,691	Feb 25 05:22 PM
Saxonov Serge	Officer	Feb 24 '25	Proposed Sale	11.56	5,104	59,002		Feb 24 08:01 PM
Hindson Benjamin J.	Officer	Feb 24 '25	Proposed Sale	11.56	4,563	52,748		Feb 24 07:35 PM
Saxonov Serge	Chief Executive Officer	Dec 23 '24	Option Exercise	1.20	12,000	14,400	884,574	Dec 23 08:29 PM
Saxonov Serge	Chief Executive Officer	Nov 22 '24	Sale	13.69	6,693	91,612	872,574	Nov 25 04:53 PM
Hindson Benjamin J.	See Remarks	Nov 22 '24	Sale	13.69	5,807	79,485	339,897	Nov 25 04:52 PM
Hindson Benjamin J.	Officer	Nov 22 '24	Proposed Sale	13.32	5,734	76,377		Nov 22 04:56 PM
Saxonov Serge	Officer	Nov 22 '24	Proposed Sale	13.32	6,608	88,019		Nov 22 04:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TXG

10x Genomics Inc

Upgrade your FINVIZ experience